Davide Leone & Partners Investment CO Ltd. Allakos Inc. Transaction History

Davide Leone & Partners Investment CO Ltd.

$22.9 Million
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$85.37 - $114.1 $1.22 Million - $1.63 Million	-14,253 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $1.13 Million - $2.17 Million	14,253 New	14,253 $2 Million

Others Institutions Holding ALLK

# of Institutions

Shares Held

70.7M

Call Options Held

43.8K

Put Options Held

1.4K

Bvf Inc San Francisco, CA

16.6M
Shares

$20.7 Million
0.51% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$7.68 Million
0.58% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$6.25 Million
0.16% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$4.39 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.42M
Shares

$4.28 Million
0.0% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $106M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davide Leone & Partners Investment CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davide Leone & Partners Investment CO Ltd. with notifications on news.

Account